Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,101–2,200 of 3,349
Exercise conditioned plasma dampens inflammation via clusterin and boosts memoryPreprint
Miguel, Z. D., Betley, M. J., Willoughby, D., Lehallier, B., Olsson, N., Bonanno, L. N., Fairchild, J. K., Contrepois, K., Elias, J. E., Rando, T. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/775288 · Cited by 8
Wang, H. V., Xiang, J., Yuan, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.12.523820 · Cited by 8
Repetitive head impacts induce neuronal loss and neuroinflammation in young athletesPreprint
Butler, M. L. M. D., Pervaiz, N., Breen, K., Calderazzo, S. M., Ypsilantis, P., Wang, Y., Breda, J. C., Mazzilli, S. A., Nicks, R., Spurlock, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.26.586815 · Cited by 8
“RHIM2 expressed C1QA, C1QB, C1QC, and CAMK2D the components and downstream effector of the C1q complement cascade known to drive aberrant synaptic engulfment in the neurodegenerative brain 21 .”
Xie, M., Miller, A. S., Pallegar, P. N., Umpierre, A. D., Liang, Y., Wang, N., Zhang, S., Nagaraj, N. K., Fogarty, Z. C., Ghayal, N. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.30.601396 · Cited by 8
Palomino, P. A. P., Black, K. C., & Ressl, S. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220439 · Cited by 7
Su, P., Yan, S., Chen, K., Huang, L., Wang, L., Lee, F. H. F., Zhou, H., Lai, T. K. Y., Jiang, A., Samsom, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02396-2 · Cited by 7
“Colocalizations were quanti fi ed using ImageJ software as previously described [45, 46] in four random regions of interest (ROIs) in the cortex.”
Wu, H., Chen, S., Zhang, W., Lu, Y., Zheng, J., Chang, J., & Chiou, J. A. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250069 · Cited by 8
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 9
Almalki, W. H., & Almujri, S. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155614 · Cited by 9
Sohail, A., Shams, F., Nawaz, A., Ain, Q. U., & Ijaz, B. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111384 · Cited by 8
Patil, S. P., Kuehn, B. R., McCullough, C., Bates, D., Hazim, H., Diallo, M., & Francois, N. (2025) · Molecules · doi:10.3390/molecules30040940 · Cited by 10
“…accumulation before other AD-related phenotypes, including neurofibrillary τ tangle formation, reactive gliosis, activated microglia and complement pathways, severe inflammation, early synapse loss, and neuro-Molecules transmitter deficit, leading in turn to irreversible cognitive impairment [7–9].”
Microglia target synaptic sites early during excitatory circuit disassembly in neurodegeneration
Yu, A. K., Fang, C., Tan, L. X., Lakkaraju, A., Santina, L. D., & Ou, Y. (2025) · iScience · doi:10.1016/j.isci.2025.112201 · Cited by 11
McCrea, L. T., Batorsky, R., Bowen, J. J., Yeh, H., Thanos, J. M., Fu, T., Perlis, R. H., & Sheridan, S. D. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02123-1 · Cited by 8
Vataja, E., Ratti, G., Safa, A., Pagano, M., Ferrante, L., Meri, S., & Haapasalo, K. (2025) · Inflammation Research · doi:10.1007/s00011-025-02069-6 · Cited by 8
“In the absence of C1q and CR3, the neurotoxic effects of Aβ are diminished, as demonstrated in an AD mouse model [ 36].”
InfluentialGlial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
Sil, M., Mukherjee, N., Chatterjee, I., Ghosh, A., & Goswami, A. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02379-8 · Cited by 10
Bi, S., Chen, Z., Li, Y., Cui, B., Shan, Y., Yang, H., Qi, Z., Wu, L., Yan, S., & Lu, J. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07485-8 · Cited by 14
“Different from glucose metabolism disorders, Aβ, as an early pathological event, may indirectly destroy transmitter homeostasis through global mechanisms such as synaptic toxicity and neuroinflammation [67 – 69].”
Paoli‐Iseppi, R. D., Joshi, S. S., Gleeson, J., Prawer, Y. D. J., You, Y., Agarwal, R., Li, A., Hull, A., Whitehead, E. M., Seo, Y., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03724-1 · Cited by 17
Pinto, A., Haytural, H., Loss, C. M., Álvarez, C., Ertas, A., Curtis, O., Williams, A. R., Murphy, G., Salleng, K. J., Gografe, S., et al. (2025) · Aging Cell · doi:10.1111/acel.70242 · Cited by 10
“These proteins are well-known to be dysregulated in AD pathogenesis (Hong et al. 2016; Jankowsky et al. 2004).”
Wu, Q., Cong, P., Li, Z., Zhang, Y., Wu, H., Zhang, Q., Li, Y., Li, T., Miao, Q., Zheng, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202502034 · Cited by 12
Wang, J., Wu, J., Ma, X., Wu, Y., Xiao, Z., Zhou, X., Ding, D., & Zhao, Q. (2025) · Aging and Health Research · doi:10.1016/j.ahr.2025.100267 · Cited by 7
Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease
Ghosh, S., Bhaskar, R., Singh, K. K., Sharma, S., Yarlagadda, B., Sinha, J. K., & Han, S. S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01651-0 · Cited by 11
Ye, Q., Gao, W., Feng, J., Li, X., Li, J., Yang, F., Li, L., Zi, M., Wu, X., Gao, H., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71185 · Cited by 11
“46 Similarly, enhanced C3 expression in the whole brain, especially in the hippocampus, was also observed in 5 × FAD mice and tau P301S mice, whilethischangebeingsignificantlypositivelycorrelatedwithamyloid deposition or tau levels.”
Wang, S., Ponnusamy, M., Patel, O., Hansen, M. T., Collier, L. A., Collier, S., & Thinakaran, G. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01652-z · Cited by 7
“Notably, Pgk1 , which encodes an essential glycolytic enzyme, is upregulated in the CA3 region as an early metabolic response to pathological tau accumulation.”
In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Hall‐Roberts, H., Daniel, E. D., James, W., Davis, J. B., & Cowley, S. A. (2021) · Journal of Visualized Experiments · doi:10.3791/62217 · Cited by 13
Faborode, O. S., Dallé, E., & Mabandla, M. V. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107611 · Cited by 9
Meng, X., Xue, J., Su, S.-J., Gou, J., Lu, J., Chen, C.-L., & Xu, C. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2145426 · Cited by 11
“Excessive activation of microglia causes enhanced cell proliferation and migration, which leads to synaptic loss and cognitive decline in AD patients by excessive phagocytosis and clearance of synapses [22,23].”
BackgroundCurrent study on diagnosis and treatment of Alzheimer’s disease by targeting amyloid b-protein
Hua, K.-Y., & Zhao, W. (2022) · Folia Neuropathologica · doi:10.5114/fn.2022.119778 · Cited by 9
Altered Synaptic Plasticity: Plausible Mechanisms Associated With Viral Infections
Saini, V., Rani, A., Kumar, A., Jha, K., Karnati, S., & Jha, H. C. (2023) · Future Virology · doi:10.2217/fvl-2023-0105 · Cited by 7
Shibata, M., Makioka, K., Nakamura, T., Kasahara, H., Yamazaki, T., Takatama, M., Okamoto, K., & Ikeda, Y. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137642 · Cited by 7
You, Y., An, D., Wan, Y., Zheng, B.-X., Dai, H., Zhang, S., Zhang, X., Wang, R., Shi, P. D., Jin, M., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05111-0 · Cited by 9
“Cerebral ischemia prolongs microglia-synapse contacts, which prunes presynaptic boutons [12], and microglia contribute to early synapse loss in Alzheimer's disease through pruning synapses [13, 14].”
BackgroundReyes, C. D. G., Atashi, M., Fowowe, M., Onigbinde, S. B., Daramola, O. E., Lubman, D. M., & Mechref, Y. S. (2024) · PROTEOMICS · doi:10.1002/pmic.202300620 · Cited by 10
Liang, Y., Yang, Y., Jie, Z., Xu, K., Xu, H., Zhang, H., & Wu, X. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04296-0 · Cited by 9
“In addition, neuroinflammation also leads to neuronal synapse loss [36].”
Changes in Neuroimmunological Synapses During Cerebral Ischemia
Bitar, L., Puig, B., Oertner, T. G., Dénes, Á., & Magnus, T. U. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01286-1 · Cited by 11
“However, recent studies have also suggested that dysregulated microglia/macrophages damage synapses in Alzheimer’s disease and viable neurons in stroke [161–164].”
Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology
Boon, B. D. C., Frigerio, I., de Gooijer, D., Morrema, T. H. J., Bol, J. G. J. M., Galis, Y., Heymans, M. W., Bank, N. B., Murray, M. E., Amsterdam, N. A. B. C., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.13009 · Cited by 8
Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors
Carlsen, J., Fossati, S., Østergaard, L., Gutiérrez‐Jiménez, E., & Palmfeldt, J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70122 · Cited by 7
“69 We note that CLU, as well as the protein Vitronectin (VTN), that are both complement inhibitors were both upregulated as well in all four studies (Table 1).”
Salvianolate reduces neuronal apoptosis by suppressing OGD-induced microglial activation
Luan, P., Ding, X., Xu, J., Jiang, L., Xu, Y., Zhu, Y., Li, R., & Zhang, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118393 · Cited by 7
Roles of microglial membranes in Alzheimer's disease
Shin, J., & Lee, J. C. (2020) · Current topics in membranes · doi:10.1016/bs.ctm.2020.08.007 · Cited by 7
“For example, microglia mediate early synapse loss in AD (Hong et al., 2016; Rajendran & Paolicelli, 2018).”
BackgroundBispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
Quint, W. H., Matečko‐Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. M., & Vogels, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201334 · Cited by 7
“25μg for bispecific antibodies to have equal numbers of antibody molecules under all conditions [33].”
BackgroundMethodInfluentialAn ELISA-based method for rapid genetic screens in Drosophila
Jay, T. R., Kang, Y., Jefferson, A., & Freeman, M. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107427118 · Cited by 7
Savonenko, A. V., Wong, P. C., & Li, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00022-8 · Cited by 9
Vadászi, H., Kiss, B., Micsonai, A., Schlosser, G., Szaniszló, T., Kovács, R. Á., Györffy, B. A., Kékesi, K. A., Goto, Y., Uzonyi, B., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102113 · Cited by 9
“C1q serves as a signal on synapses that need to be eliminated; however, the detailed molecular mechanisms are still unexplored (13, 19).”
BackgroundPradhan, A. K., Shi, Q., Tartler, K. J., & Rammes, G. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101687 · Cited by 8
Self-citationTautou, M., Descamps, F., Larchanché, P.-E., Buée, L., Bakali, J. E., Melnyk, P., & Sergeant, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065285 · Cited by 7
“C3 inhibition has been confirmed by others to reduce the number of pro-inflammatory microglia, decreasing synaptic and neuronal loss [60,61].”
BackgroundPathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells
Zhang, C., Raveney, B. J. E., Takahashi, F., Yeh, T.-W., Hohjoh, H., Yamamura, T., & Oki, S. (2023) · Cells · doi:10.3390/cells12060868 · Cited by 10
Emerging concepts towards a translational framework in Alzheimer’s disease
Cozachenco, D., Zimmer, E. R., & Lourenco, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105246 · Cited by 8
Li, Q., Kang, X., Liu, L., Xiao, Y. M., Xu, D., Zhuang, H., Liu, H., Zhao, J., Zou, H., Yang, J., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106181 · Cited by 7
Ma, X., Le, Y., Hu, L., Ouyang, W., Li, C., Ma, D., & Tong, J. (2024) · Brain Pathology · doi:10.1111/bpa.13253 · Cited by 7
“For instance, microglia mediated the synaptic loss in Alzheimer ’ s disease [12]; the phagocytosis of microglia led to depressive disorder [29].”
Complement mediates pathological pruning
Whalley, K. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.52 · Cited by 7
New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia
Khachaturian, A. S., Hayden, K. M., Mielke, M. M., Tang, Y., Lutz, M. W., Gold, M., Kukull, W. A., Mohs, R. C., Gauthier, S. G., Molinuevo, J. L., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.002 · Cited by 8
Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
LoPresti, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00973 · Cited by 9
“A second mechanism involves microglia directly pruning synapses via a complement-mediated mechanism, which has also been described during development and adult life (41).”
BackgroundOhgomori, T., & Jinno, S. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24734 · Cited by 7
“Recent studies have shown that microglia are involved in phagocyto- sis of synaptic components (Aono et al., 2017; Hong et al., 2016).”
BackgroundInfluentialEffect of cerebral small vessel disease on cognitive function and TLR4 expression in hippocampus
Zhang, Y., Zhang, Y., Wu, R., Gao, F., Zang, P., Hu, X., & Gu, C. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.06.038 · Cited by 7
MacKenzie, G., Subramaniam, S., Caldwell, L. J., Fitzgerald, D. C., Harrison, N. A., Hong, S. Y., Irani, S. R., Khandaker, G. M., Liston, A., Miron, V. E., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16997.1 · Cited by 8
Self-citationZhao, Y., Qiao, S., Zhang, B., Cao, Y., Tian, H., Liu, R., Sun, L., Cao, W. F., Li, L., Wang, R. L., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133090 · Cited by 8
Nakagawa, K., Ueda, M., Itoh, M., Islam, S., Tana, T., & Nakagawa, T. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000234 · Cited by 6
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2019) · doi:10.1101/639054 · Cited by 7
Zarantonello, A., Pedersen, H., Laursen, N. S., et al. (2021) · Preprints.org · doi:10.20944/preprints202101.0151.v1 · Cited by 7
Glial Regulation of Circuit Wiring, Firing, and Expiring in theDrosophilaCentral Nervous System
Coutinho‐Budd, J., Freeman, M. R., & Ackerman, S. D. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041347 · Cited by 9
Richards, T., Perron, J. C., Patel, K., Wurpel, J., Reznik, S. E., & Schanne, F. (2023) · doi:10.21203/rs.3.rs-3399248/v1 · Cited by 6
“Results demonstrated a reduction in neuroin�ammation but the inhibitor of C1q also reduced opsonization and immune clearance [25].”
BackgroundMethodInfluentialSakkaki, E., Jafari, B., Gharesouran, J., & Rezazadeh, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09113-w · Cited by 8
“Specifically, microglia-mediated inflammation and aberrant cytokine responses could lead to neuronal damage, synaptic dysfunction, and cognitive decline in AD [37, 38].”
Reducing brain Aβ burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice
Tsay, H.-J., Gan, Y., Su, Y., Sun, Y., Yao, H.-H., Chen, H., Hsu, Y.-T., Hsu, J. T., Wang, H., & Shie, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116404 · Cited by 6
Neuroplasticity elicited by peripheral immune challenge with a viral mimetic
Konat, G. W. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149239 · Cited by 5
Schröder, S., Sakib, M. S., Krüger, D., Peña, T., Burkhardt, S., Schütz, A., Sananbenesi, F., & Fischer, A. (2025) · Non-Coding RNA · doi:10.3390/ncrna11010002 · Cited by 8
Ao, J., Picard, C., Auld, D. S., Zetterberg, H., Brinkmalm, A., Blennow, K., Villeneuve, S., Breitner, J. C. S., Poirier, J., Breitner, J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-024-02884-z · Cited by 12
“Such tau -associated synaptic degeneration and engulfment are probably responsible for much of the cognitive de fi cit in AD, which, importantly, might be obviated if synaptic degeneration could be prevented [14, 15, 17].”
Yuasa‐Kawada, J., Kinoshita-Kawada, M., Hiramoto, M., Yamagishi, S., Mishima, T., Yasunaga, S., Tsuboi, Y., Hattori, N., & Wu, J. Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01330 · Cited by 11
“Additionally, complement receptors and Fc receptors expressed in microglia activate both innate and adaptive immune systems and are linked to microglial engulfment-mediated synaptic loss in AD (Hong et al, 2016; Leng and Edison, 2021).”
The Impact of the Exposome on Alzheimer’s Disease: The Influence of Nutrition
Monaco, M., Torazza, C., Fedele, E., & Grilli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073015 · Cited by 8
“Additionally, A β peptides contribute to inflammation [6], tau hyperphosphorylation [7], and, ultimately, cell death [8].”
Mouse models of Anti-Aβ immunotherapies
Pikus, P., Turner, R. S., & Rebeck, G. W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00836-x · Cited by 7
“These mice exhibit synaptic deficits, neuronal loss, and neuroinflammation before signs of plaque deposition [29, 30].”
Testen, A., VanRyzin, J. W., Bellinger, T. J., Kim, R., Wang, H., Gastinger, M. J., Witt, E. A., Franklin, J. P., Vecchiarelli, H. A., Picard, K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116137 · Cited by 15
“36,37 These findings suggest a glia-glia interaction, involving microglial engulfment of peripheral astrocyte processes following prolonged cocaine self-administration and abstinence, which may contribute to the atrophic phenotype of astrocytes observed in this study.”
Chen, L., Li, Z., Gao, Y., Piao, G., Li, Y., Hong, J., Wang, Q., Liu, K., Wang, J., Du, A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03554-9 · Cited by 8
“It has been reported that C1q expression is increased in the hippocampus and prefrontal cortex of a mouse model of Alzheimer’s disease, and that the inhibition of C1q expression or the antagonism of its receptor can reduce phagocytic microglial numbers and synaptic loss [30].”
Zhou, J., Guo, X., Yu, W., Bu, H., Du, Y., Li, S., Kuang, H., & Wu, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148017 · Cited by 7
Self-citationWard, E., Benowitz, L. I., Brunner, T. M., Bu, G., Cayouette, M., Canto-Soler, V., Mesquita, S. D., Polo, A. D., DiAntonio, A., Duan, X., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00858-5 · Cited by 8
“…complement system is one of several neuroimmune systems that have proven to be general mechanisms for pathological synapse loss in multiple neurodegenerative diseases, including glaucoma [79], Alzheimer’s Disease (AD) [81], multiple sclerosis (MS) [82, 83], and Huntington’s disease (HD) [63, 70].”
Self-citationDelcy, S. A. S., Farrugia, A. M., Nieves, I. A. D., O’Brien, C. A., Bennett, F. C., & Cohen, A. S. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106178 · Cited by 5
“Microglia interact with neurons via signaling molecules and play key roles in synaptic pruning during development and disease (Hong et al., 2016a; Hong et al., 2016b; Cornell et al., 2022).”
A ketogenic diet improves memory in females in the APOE4 mouse model of Alzheimer’s disease
Lucente, J. D., Rutkowsky, J. M., Provenzano, A. E., Persico, G., Zhou, Z., Jin, L., Ramsey, J. J., Montgomery, C. B., Kim, K., Giorgio, M., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01998-8 · Cited by 10
“Thus, it is possible that the KD, by suppressing inflammation peripherally and in the CNS, improves memory outcomes [41].”
Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's disease
Mangalmurti, A., Zengeler, K. E., Hollis, A., Golden, E., Riddlemoser, G., & Lukens, J. R. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70943 · Cited by 10
Peng, Y., Mulat, Y., Yang, Z., Fu, C., Huo, Y., Wang, P., Wang, R., Ren, Z., Zhang, H., Hu, Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-09167-5 · Cited by 9
Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer’s Disease
Mishra, A. K., & Jain, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00750 · Cited by 13
Mavrych, V., Mansour, G. K., Hajjar, A. W., & Bolgova, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010084 · Cited by 12
“HLA-DRB5 , a major histocompatibility complex class II gene, is expressed on reactive microglia in Alzheimer’s and Parkinson’s disease brains; upregulation of HLA-DR reflects inflammatory activation and aberrant microglial responses that may contribute to synaptic dysfunction [56,57].”
Ma, Y., Zhang, J., Zhou, Q., Tang, P., Wang, X., Zhu, H., Huang, Z., Su, H., Zhai, X., & Wang, Q. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119697 · Cited by 7
Trained immunity in acute and chronic neurological diseases
Zhang, S., & Liesz, A. (2026) · eLife · doi:10.7554/elife.106037 · Cited by 7
“On the other hand, they can contribute to neurodegeneration by releasing toxic substances that damage neurons and mediate synapse loss through complement-dependent mechanisms ( Hansen et al., 2018 ; Hong et al., 2016 ).”
C1q is related to microglial phagocytosis in the hippocampus in physiological conditions
Díaz‐Aparicio, I., & Sierra, A. (2019) · Matters · doi:10.19185/matters.201904000013 · Cited by 5
“However, detrimental functions of C1q have also been suggested upon deregulation in neurodegenerative diseases such as Alzheimer’s Disease, in which C1q increases synapse targeting and promote an excessive elimination and synapse loss by microglia [16].”
BackgroundTon, S. T., Laghi, J. R., Tsai, S., Blackwell, A. A., Adamczyk, N. S., Oltmanns, J. R. O., Britten, R. A., Wallace, D. G., & Kartje, G. L. (2022) · Radiation Research · doi:10.1667/rade-21-00021.1 · Cited by 6
“Although microglia function as immune cells in the central nervous system (CNS), they also play an important role in regulating synaptic plasticity, synapse number (33, 34), neurogenesis (35–37), and rewiring of neural circuits (38–41).”
BackgroundKuhrt, L. D., Motta, E., Elmadany, N., Weidling, H., Fritsche‐Guenther, R., Efe, I. E., Cobb, O. M., Chatterjee, J., Boggs, L. G., Schnauss, M., et al. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049861 · Cited by 8
“…implicated as key regulators of neurodevelopmental, neuro-oncological and neurodegenerative disorders, including autism (Derecki et al., 2012; Kana et al., 2019), brain cancer (Hambardzumyan et al., 2016; Pasqualini et al., 2020), and Alzheimer ’ s dementia (Hong et al., 2016; Leyns et al., 2019).”
Adhikari, A., Chauhan, K., Adhikari, M., & Tiwari, A. K. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117628 · Cited by 7
Patil, S. P., & Kuehn, B. R. (2024) · Pharmaceuticals · doi:10.3390/ph17040491 · Cited by 8
“The abnormal A β deposits in the AD brain are known to initiate a deleterious cascade of events involving the formation of neurofibrillary tangles of tau, reactive gliosis, activated microglia and complement pathways, severe inflammation, early synapse loss, and neurotransmitter deficit [2,6,7].”
BackgroundComplement propagates visual system pathology following traumatic brain injury
Borucki, D. M., Rohrer, B., & Tomlinson, S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03098-4 · Cited by 11
“C3 opsonization has been shown to guide microglial phagocytosis within the central nervous system [13, 14, 29].”
BackgroundEarly Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice
Rombaut, B., Schepers, M., Tiane, A., Mussen, F., Koole, L., Kessels, S., Trippaers, C., Jacobs, R., Wouters, K., Willems, E., et al. (2024) · Cells · doi:10.3390/cells13121000 · Cited by 8
“Female monoallelic APPswe/PS1dE9 mice and WT littermates were injected daily a PDE4B inhibitor, A33 (3 mg/kg), from postnatal 1–4 months, which is the time window that high levels of synapse loss are observed but before cognitive decline is to be expected (7–8 months) [45].”
BackgroundMethodInfluentialCuevas-Ríos, G., Assale, T. A., Wißfeld, J., Bungartz, A., Hofmann, J. D., Langmann, T., & Neumann, H. (2024) · Glia · doi:10.1002/glia.24613 · Cited by 8
“Degenerating neurons are often opsonized by complement factors before they are cleared by microglial phagocytosis (Hong et al., 2016; Werneburg et al., 2020).”
Schartz, N. D., Li, Y., Sommer, A. L., & Brewster, A. L. (2024) · Epilepsia Open · doi:10.1002/epi4.13030 · Cited by 7
Complement Component 3 Promotes Regeneration of Olfactory Receptor Neurons
Kuwazoe, H., Sakatani, H., Kono, M., Saika, S., Inoue, N., & Hotomi, M. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102200 · Cited by 6
Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
Calvin, K., McNeela, A. M., Osse, A. M. L., Bhasin, G., Ridenour, M., Kinney, J. W., & Hyman, J. M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105987 · Cited by 8
Neurobiological mechanisms of forgetting across timescales
de Snoo, M. L., & Frankland, P. W. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.102972 · Cited by 8
Neuroimmune regulation of the prefrontal cortex tetrapartite synapse
Liss, A., Siddiqi, M. T., Marsland, P., & Varodayan, F. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110335 · Cited by 8
“…generally display a down-regulation of neuro-and synapto-protective factors (e.g. PI3K/Akt pathway, growth factors like brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor) and an upregulation of the complement cascade (Hong et al., 2016; Lawrence et al., 2023).”
Xue, R., Gao, P., Chen, Y.-M., Liu, Y., Han, B., Huang, Y., Mi, Y., Cui, R., Lin, Y., Wang, Z.-T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251322808 · Cited by 6
“14 The current study concentrates on a sizable cohort of thoroughly characterized individuals presenting with bio-marker indicators of AD pathology.”
InfluentialSüß, P. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1480-17.2017 · Cited by 6
Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways
Bryan, J., Mandan, A., Kamat, G., Gottschalk, W. K., Badea, A., Adams, K. J., Thompson, J. W., Colton, C. A., Mukherjee, S., Lutz, M. W., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12223 · Cited by 6
Costanzo, F., Zanni, G., Fucà, E., Paola, M. D., Barresi, S., Travaglini, L., Colafati, G. S., Gambardella, A., Bellacchio, E., Bertini, E., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031224 · Cited by 8
Petralia, M. C., Mangano, K., Quattropani, M. C. A., Lenzo, V., Nicoletti, F., & Fagone, P. (2022) · Brain Sciences · doi:10.3390/brainsci12070827 · Cited by 7
Acquired immunity and Alzheimer's disease
Feng, W., Zhang, Y., Sun, P. G., & Xiao, M. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220083 · Cited by 9
Zhang, C., Shi, G., Li, G., Zuo, K., Bai, X., Qi, M., & Huang, M. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152275 · Cited by 6
iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes
Zhou, X., Sheikh, A. M., Matsumoto, K., Mitaki, S., Shibly, A. Z., Zhang, Y., Garu, A., Yano, S., & Nagai, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010672 · Cited by 8
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.